|
Re: Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failure
|
13
|
Resverlogix Corp.
|
Jan 12, 2021 03:53PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
9
|
Resverlogix Corp.
|
Mar 18, 2022 12:24PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
17
|
Resverlogix Corp.
|
Mar 17, 2022 04:31PM
|
|
Re: Article
|
8
|
Resverlogix Corp.
|
May 30, 2022 11:40AM
|
|
Re: As Pfizer charges ahead....
|
4
|
Resverlogix Corp.
|
Sep 09, 2021 12:05PM
|
|
Re: As Pfizer charges ahead....
|
6
|
Resverlogix Corp.
|
Sep 04, 2021 09:44AM
|
|
Re: As Pfizer charges ahead....
|
4
|
Resverlogix Corp.
|
Sep 09, 2021 06:00PM
|
|
Re: ASN late breaker and CKD sub-study top-line
|
6
|
Resverlogix Corp.
|
Oct 10, 2019 10:05AM
|
|
Re: Bear
|
4
|
Zenith Epigenetics
|
Apr 16, 2018 08:07PM
|
|
Re: Bear
|
1
|
Zenith Epigenetics
|
Apr 17, 2018 01:35PM
|
|
Re: Bear
|
|
Zenith Epigenetics
|
Apr 17, 2018 05:13PM
|
|
Re: BETOnMACE CHF and eGFR
|
1
|
Resverlogix Corp.
|
Mar 28, 2020 08:23PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
4
|
Resverlogix Corp.
|
Sep 03, 2021 09:12AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 28, 2017 10:05PM
|
|
Re: BETonMACE Enrollment
|
4
|
Resverlogix Corp.
|
Aug 29, 2017 09:29AM
|
|
Re: BetonMace Phase 111 Trial opinions...
|
7
|
Resverlogix Corp.
|
Jun 05, 2015 12:28AM
|
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 21, 2019 11:29AM
|
|
Re: BETting on a new heart failure treatment
|
3
|
Resverlogix Corp.
|
May 18, 2017 01:38PM
|
|
Re: BETting on a new heart failure treatment
|
1
|
Resverlogix Corp.
|
May 18, 2017 02:14PM
|
|
Re: Big Drop in Zenith today!
|
2
|
Zenith Epigenetics
|
May 05, 2023 08:20PM
|
